Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The expression of HER2-gene polymorphisms -1985G>T and P1170A C>G and their association with the risk of development of lung adenocarcinoma (CROSBI ID 681606)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Aleric, Ivan ; Katalinic, Darko ; Vcev, Aleksandar ; Kattner, Elke ; Bildat, Stephan, Krieger-Borgstaedt, Veronica ; Toetome, Lars The expression of HER2-gene polymorphisms -1985G>T and P1170A C>G and their association with the risk of development of lung adenocarcinoma // Annals of oncology / x, x (ur.). 2019. str. x-x doi: 10.1093/annonc/mdz260.077

Podaci o odgovornosti

Aleric, Ivan ; Katalinic, Darko ; Vcev, Aleksandar ; Kattner, Elke ; Bildat, Stephan, Krieger-Borgstaedt, Veronica ; Toetome, Lars

engleski

The expression of HER2-gene polymorphisms -1985G>T and P1170A C>G and their association with the risk of development of lung adenocarcinoma

Background: HER2-gene mutations are considered to be an important prognostic factor in patients with lung cancer. The aim of our study was to assess the frequency and signicance of HER2-gene single nucleotide polymorphisms -1985G>T and P1170AC>G among the patients with small-cell and non-small cell lung cancer and to compare this data to healthy subjects. Methods: The study was performed among 359 patients (69% males and 31% females ; mean age of 59.96 ± 18.24 years) with diagnosis of stage IV small-cell (24.6% of patients) and nonsmall cell lung cancer (75.4% of patients) compared to 167 healthy subjects (72% males and 28% females ; mean age of 69.96 ± 11.74 years). The frequencies of two polymorphisms of the HER-2-gene -1985G>T and P1170A C>G were detected using the quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) assay. The study was conducted according to the Declaration ofHelsinki, the protocol was reviewed and approved by the institutional Ethics committee and all patients provided written informed consent. Results: We found statistically signicant dierence in the distribution of genetic mutation variants -1985G>T and P1170A C>G among the patients with lung adenocarcinoma compared to healthy subjects (p < 0.001). The -1985G>T and P1170A C>G allelic variants were not signicantly expressed among the patient and control groups in overall subject (p = 0.874). Conclusions: Our study indicates that the expressions of genetic variants -1985G>T and P1170A C>G is associated with higher risk of development of lung adenocarcinoma. There was no statistical dierence among patient and control groups in overall subjects.

HER2-gene polymorphism, 1985G>T, P1170A C>G, lung adenocarcinoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

x-x.

2019.

nije evidentirano

objavljeno

10.1093/annonc/mdz260.077

Podaci o matičnoj publikaciji

Annals of oncology

x, x

Barcelona: Oxford University Press

0923-7534

1569-8041

Podaci o skupu

44th Congress of the European Society for Medical Oncology (ESMO)

poster

27.09.2019-01.10.2019

Barcelona, Španjolska

Povezanost rada

Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti, Dentalna medicina

Poveznice
Indeksiranost